Subscribe to Newsletter

Manufacture


Manufacture Vaccines

Towards Spray Dried RNA Vaccines

| Stephanie Vine | 5 min read

Biotech company Ethris explains the benefits and challenges of developing spray dried RNA vaccines.

Manufacture Advanced Medicine

The Era of Armored CAR Ts

| Stephanie Vine | 2 min read

Carl June and UPenn researchers develop next generation CAR T cell therapy and demonstrate promising results in phase I trial.

Manufacture Contract Development Services

Streamlining Biologics from IND to Commercial Scale with Continuous Manufacturing

| Nick Hutchinson | 4 min read

When it comes to continuous cGMP biomanufacturing, Just – Evotec Biologics’ J.DESIGN platform integrates data analytics and continuous manufacturing

Manufacture Advanced Medicine

Characterizing CAR T Cells

| Stephanie Vine | 2 min read

Researchers develop new approach that could help with CAR T manufacturing.

Manufacture Advanced Medicine

Inhalable Gene Therapies? Here’s How They Could Work

| Stephanie Vine | 5 min read

Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Manufacture Advanced Medicine

Gene Therapy Research Roundup: Gene Circuits and Controlling Capsids With Machine Learning

| 3 min read

We look at some of the latest studies and research announcements focused on improving gene therapy.

Manufacture Advanced Medicine

Kite, CAR Ts, and Access for Patients

| Stephanie Vine | 9 min read

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

Manufacture Facilities

FUJIFILM Diosynth and Regeneron Sign 10-Year, $3 Billion Manufacturing Agreement

| Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Manufacture Advanced Medicine

Advancing AAV Manufacturing Quality

| Efrain Guzman | 3 min read

Overcoming the limitations of the triple plasmid transient transfection method for AAV manufacturing.

Manufacture Advanced Medicine

Cell Therapy: Getting GMP Right

| Stephanie Vine | 2 min read

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register